Paclitaxel Patents (USA)
(Update Feb. 2003)
Paclitaxel Story   Paclitaxel 
full information
Paclitaxel Injection 
full information
Paclitaxel 
Clinical Trials
 
Paclitaxel mechnism
Quality Control of Paclitaxel bulk Quality Control of Paclitaxel Injection Paclitaxel 
Patents
Price How to Order
 Total 939 Paclitaxel related US patents (from US Patent & Trademark Office)

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

 

No. 1 - 100 Paclitaxel Patents:

PAT. NO.                                      Title
1 6,515,151 Full-Text Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof
2 6,515,017 Full-Text Water soluble paclitaxel derivatives
3 6,515,016 Full-Text Composition and methods of paclitaxel for treating psoriasis
4 6,515,009 Full-Text Therapeutic inhibitor of vascular smooth muscle cells
5 6,515,004 Full-Text N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
6 6,514,983 Full-Text Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
7 6,514,738 Full-Text KinI-3 motor protein and methods for its use
8 6,514,535 Full-Text Bioadhesive hydrogels with functionalized degradable crosslinks
9 6,514,491 Full-Text Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10 6,514,193 Full-Text Method of administering a therapeutically active substance
11 6,512,123 Full-Text Tricyclic alkylhydroxamate derivatives
12 6,511,973 Full-Text Lactam inhibitors of FXa and method
13 6,511,676 Full-Text Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
14 6,509,491 Full-Text Aminohydroxylation of olefins in the presence of acetamide
15 6,509,484 Full-Text Synthesis of taxol, taxol analogs and their intermediates with variable a-ring side chain structures and compositions thereof
16 6,509,370 Full-Text Paclitaxel formulation
17 6,509,316 Full-Text Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
18 6,506,910 Full-Text Process for preparing discodermolide and analogues thereof
19 6,506,905 Full-Text Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
20 6,506,799 Full-Text Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
21 6,506,798 Full-Text 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
22 6,506,783 Full-Text Cancer treatments and pharmaceutical compositions therefor
23 6,506,437 Full-Text Methods of coating an implantable device having depots formed in a surface thereof
24 6,506,411 Full-Text Anti-angiogenic compositions and methods of use
25 6,506,408 Full-Text Implantable or insertable therapeutic agent delivery device
26 6,506,405 Full-Text Methods and formulations of cremophor-free taxanes
27 6,506,399 Full-Text Biodegradable botulinum toxin implant
28 6,503,954 Full-Text Biocompatible carrier containing actinomycin D and a method of forming the same
29 6,503,893 Full-Text Method of treating hyperproliferative diseases using active vitamin D analogues
30 6,503,556 Full-Text Methods of forming a coating for a prosthesis
31 6,503,481 Full-Text Compositions for aerosolization and inhalation
32 6,503,396 Full-Text Method and apparatus for preparing taxol using supercritical fluid from source materials
33 6,503,184 Full-Text Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
34 6,500,966 Full-Text Process for the preparation of taxanes from 10-deacetylbaccatin III
35 6,500,868 Full-Text Method for preventing and treating peripheral neuropathy by administering selegiline
36 6,500,858 Full-Text Taxoid anti-tumor agents and pharmaceutical compositions thereof
37 6,500,853 Full-Text Inhibitors of phospholipase enzymes
38 6,500,461 Full-Text Particulate formulations
39 6,500,431 Full-Text Inhibitors of angiogenesis and tumor growth
40 6,500,405 Full-Text Use of certain amides as probes for detection of antitubulin activity and resistance monitoring
41 6,498,945 Full-Text Sonodynamic therapy using an ultrasound sensitizer compound
42 6,498,257 Full-Text 2,3-olefinic epothilone derivatives
43 6,498,195 Full-Text Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4'-hydroxyphenyl) as an anticarcinogenic agent
44 6,498,188 Full-Text Methods of treatment for cancer or viral infections
45 6,497,904 Full-Text Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
46 6,495,719 Full-Text Histone deacetylase inhibitors
47 6,495,705 Full-Text Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
48 6,495,663 Full-Text Method and composition for enhancing transport across biological membranes
49 6,495,659 Full-Text Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
50 6,495,600 Full-Text Method and composition for selectively inhibiting melanoma

51 6,495,594 Full-Text Biologically active analogs of discodermolide
52 6,495,579 Full-Text Method for treating multiple sclerosis
53 6,495,571 Full-Text Pyridine compounds, use and preparation thereof
54 6,495,553 Full-Text Methods and compositions for overcoming resistance to biologic and chemotherapy
55 6,495,520 Full-Text Apoptosis Inducing Molecule II and methods of use
56 6,495,161 Full-Text Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
57 6,495,129 Full-Text Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
58 6,494,862 Full-Text Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
59 6,492,547 Full-Text Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
60 6,492,379 Full-Text Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
61 6,491,938 Full-Text Therapeutic inhibitor of vascular smooth muscle cells
62 6,489,447 Full-Text Protein purification
63 6,489,369 Full-Text Phosphocholine surfactants and their use
64 6,489,314 Full-Text Epothilone derivatives and methods for making and using the same
65 6,488,962 Full-Text Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
66 6,486,204 Full-Text Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
67 6,486,202 Full-Text Inhibitors of isoprenyl transferase
68 6,486,146 Full-Text Cancer accelerants and phase synchronization methods
69 6,485,737 Full-Text Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles and methods of using the same
70 6,485,514 Full-Text Local delivery of therapeutic agents
71 6,482,932 Full-Text Nucleoside triphosphates and their incorporation into oligonucleotides
72 6,482,860 Full-Text Pentafluorobenzenesulfonamides and analogs
73 6,482,850 Full-Text Hydrolysis-promoting hydrophobic taxane derivatives
74 6,482,843 Full-Text Compounds and methods for use thereof in the treatment of cancer or viral infections
75 6,482,842 Full-Text 3-aminopyrazole inhibitors of cyclin dependent kinases
76 6,482,830 Full-Text Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
77 6,482,802 Full-Text Use of neomycin for treating angiogenesis-related diseases
78 6,482,517 Full-Text Coated particles, methods of making and using
79 6,482,439 Full-Text Drug delivery system exhibiting permeability control
80 6,482,436 Full-Text Magnetically responsive composition
81 6,479,679 Full-Text Two-step conversion of protected taxane ester to paclitaxel
82 6,479,512 Full-Text Tyrosine kinase inhibitors
83 6,479,500 Full-Text Agents for alleviating side effects
84 6,479,499 Full-Text 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
85 6,479,481 Full-Text Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
86 6,479,471 Full-Text NAALADase inhibitors
87 6,479,254 Full-Text Apoptosis inducing molecule II
88 6,479,068 Full-Text Therapeutic nutrient regimen for alleviating mucositis, stomatitis and cachexia in oncology patients
89 6,479,067 Full-Text Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
90 6,478,776 Full-Text Implant delivery catheter system and methods for its use
91 6,476,242 Full-Text 2-aroyl-4-acyl paclitaxel (Taxol) analogs
92 6,476,203 Full-Text Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
93 6,476,195 Full-Text Secreted protein HNFGF20
94 6,476,068 Full-Text Platinum derivative pharmaceutical formulations
95 6,476,066 Full-Text Anti-first-pass effect compounds
96 6,475,753 Full-Text 94 Human Secreted Proteins
97 6,475,516 Full-Text Drug delivery via therapeutic hydrogels
98 6,472,585 Full-Text Cardiotrophin-1 defective mouse
99 6,472,541 Full-Text Protecting groups with increased photosensitivities
100 6,472,512 Full-Text Keratinocyte derived interferon

 

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /



Site map:

21cecPharm Home / All about Paclitaxel / All about Docetaxel / How to Order Pharmaceuticals /  Contact us

21CEC Home  / PharmaceuticalsOrder form / GoldArt GoldPhoto / Gold Christmas Cards /GoldArt Jewelry / Order  / Contact us /

21CEP Home / Drugs Suppliers World Invest World TradeWorld Partners / World Travel / Message Board / Services    /   Contact Us /
E-Commerce Newsletter   /  21st Century Magazine      / 21st Century Cinema

 

Copyright (C) 1996 - 2003 by 21CEP 21ceps.jpg (3499 bytes)